1. Home
  2. INBS vs GMM Comparison

INBS vs GMM Comparison

Compare INBS & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBS
    SELLHOLDBUYas of in 32 minutes
  • GMM
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • INBS 2016
  • GMM 2017
  • Country
  • INBS United States
  • GMM China
  • Employees
  • INBS N/A
  • GMM N/A
  • Industry
  • INBS Medical Specialities
  • GMM
  • Sector
  • INBS Health Care
  • GMM
  • Exchange
  • INBS Nasdaq
  • GMM Nasdaq
  • Market Cap
  • INBS 16.4M
  • GMM 9.5M
  • IPO Year
  • INBS N/A
  • GMM 2023
  • Fundamental
  • Price
  • INBS $2.14
  • GMM $3.88
  • Analyst Decision
  • INBS
  • GMM
  • Analyst Count
  • INBS 0
  • GMM 0
  • Target Price
  • INBS N/A
  • GMM N/A
  • AVG Volume (30 Days)
  • INBS 259.7K
  • GMM 41.9K
  • Earning Date
  • INBS 05-07-2025
  • GMM 03-25-2025
  • Dividend Yield
  • INBS N/A
  • GMM N/A
  • EPS Growth
  • INBS N/A
  • GMM 62.17
  • EPS
  • INBS N/A
  • GMM 6.37
  • Revenue
  • INBS $3,031,405.00
  • GMM $41,360,953.00
  • Revenue This Year
  • INBS $280.88
  • GMM N/A
  • Revenue Next Year
  • INBS $126.26
  • GMM N/A
  • P/E Ratio
  • INBS N/A
  • GMM $0.63
  • Revenue Growth
  • INBS 23.21
  • GMM 53.82
  • 52 Week Low
  • INBS $1.00
  • GMM $0.21
  • 52 Week High
  • INBS $4.64
  • GMM $4.97
  • Technical
  • Relative Strength Index (RSI)
  • INBS 51.45
  • GMM 57.42
  • Support Level
  • INBS $2.04
  • GMM $3.34
  • Resistance Level
  • INBS $2.28
  • GMM $4.22
  • Average True Range (ATR)
  • INBS 0.21
  • GMM 0.35
  • MACD
  • INBS -0.03
  • GMM 0.03
  • Stochastic Oscillator
  • INBS 38.98
  • GMM 88.99

Stock Price Comparison Chart: INBS vs GMM

INBS
GMM
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250102030405060708090100110120INBS VS GMM

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use